Research news A recent meta-analysis presented at the European Congress on Obesity has found that glucagon-like peptide-1 receptor agonists and related multi-hormone obesity drugs were associated with lower systolic blood pressure in adults living with overweight or obesity A meta-analysis of 32 phase III studies involving 43,618 adults has found that contemporary obesity drugs used for weight loss were associated with a clinically relevant reduction in blood pressure, with systolic blood pressure reported to fall by 0.34 millimetres of mercury for each 1 per cent reduction in body weight
Arabidopsis peroxisomes possess functionally redundant membrane and matrix isoforms of monodehydroascorbate reductase
Liraglutide, Semaglutide, and Tirepatide all belong to the same class of medications that mimic the action of GLP-1 in the body to help reduce hunger and regulate blood sugar levels
[8] Common Research Uses Fatty-acid oxidation assays
Future development of iron-targeting therapeutics should prioritize agents with verified bloodbrain barrier permeability, minimal systemic toxicity, and the capacity to restore both iron homeostasis and redox balance
Quadmix is a compounded injectable medication that combines four active ingredients: Papaverine Phentolamine Alprostadil (Prostaglandin E1) Atropine These ingredients work together to increase blood flow to the penis by relaxing smooth muscles and dilating blood vessels
